Crossfund Sicav-Cross.M&M.Eq.F.A/ LU2208087267 /
| NAV2024-04-30 | Chg.-2.8500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 110.5800USD | -2.51% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | 4.72 | 0.06 | 4.87 | 1.69 | -3.59 | 4.78 | -0.47 | -3.31 | 3.70 | -1.11 | 2.19 | +11.40% |
| 2022 | -2.21 | 3.75 | 4.04 | -4.32 | 2.67 | -16.87 | 3.41 | 0.34 | -5.00 | 2.69 | 16.80 | -3.21 | -1.36% |
| 2023 | 9.75 | -7.97 | 0.64 | -1.41 | -7.21 | 5.76 | 5.21 | -9.17 | -2.77 | -8.36 | 6.50 | 8.95 | -2.84% |
| 2024 | -8.37 | -5.04 | 11.13 | 7.11 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 20.96% | 22.46% | 22.39% | 20.79% | -% |
| Sharpe ratio | 0.36 | 1.66 | -0.09 | -0.14 | - |
| Best month | +11.13% | +11.13% | +11.13% | +16.80% | - |
| Worst month | -8.37% | -8.37% | -9.17% | -16.87% | - |
| Maximum loss | -12.88% | -14.76% | -20.62% | -25.63% | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 97.6400 | -3.28% | -8.51% | |
| Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 101.8600 | -0.79% | -4.91% | |
| Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 110.5800 | +1.91% | +2.85% | |
| Crossfund Sicav-Cross.M&M.Eq.F.D | reinvestment | 104.5100 | +2.93% | - |
Performance
| YTD | +3.57% | ||
|---|---|---|---|
| 6 Months | +18.71% | ||
| 1 Year | +1.91% | ||
| 3 Years | +2.85% | ||
| 5 Years | - | ||
| Since start | +10.58% | ||
| Year | |||
| 2023 | -2.84% | ||
| 2022 | -1.36% | ||
| 2021 | +11.40% | ||
